Intrinsiqq
Propanc Biopharma Inc. logo

Propanc Biopharma Inc. Financials

PPCB

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 16 available years
Income Statement
JUN 2026
7:1 split
JUN 2025
~2799.6:1 split
JUN 2024
49:1 split
JUN 2023
~25.5:1 split
JUN 2022
~22.5:1 split
General & Administrative$1$0$1$1$2
Research & Development$1$0$0$0$0
Total Operating Expenses$18$57$2$2$2
Operating Income-$18-$57-$2-$2-$2
Non-Operating
Net Interest Expense-$0-$1-$1-$1-$1
Other Non-Operating Income (Expense)-$0-$1$0-$0-$0
EBT (Earnings Before Tax)-$19-$59-$2-$3-$3
Income Tax Expense––-$0-$0-$0
Net Income
Net Income-$19-$59-$2-$3-$3
EPS (Basic)-$176.20-$3,712.20-$355,132.50-$27,000,000.00-$738,450,000.00
EPS (Diluted)-$176.20-$3,712.20-$355,132.50-$27,000,000.00-$738,450,000.00
Weighted Avg Shares (Basic)1.1M4.0M85.0M1.7M68.2M
Weighted Avg Shares (Diluted)1.1M4.0M85.0M1.7M68,219
Shares Outstanding112,370.915,872.7045.670.1160.005

Propanc Biopharma (PPCB) financials: revenue, profit and margins

Propanc Biopharma (PPCB) generated about n/a in revenue and -$23 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Propanc Biopharma profitable?+

Propanc Biopharma reported about -$23 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 12 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 14 Nov 2026. How this is calculated.

Fiscal year ends Jun.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PPCB

CompareIntrinsic value
ANVSAnnovis Bio, Inc.
$0.71-5.16%10
KTTAPasithea Therapeutics Corp.
$0.48-0.48%40
TPSTTempest Therapeutics Inc.
$0.29-5.36%0
PCSAProcessa Pharmaceuticals Inc.
$1.56-7.69%10
CPIXCumberland Pharmaceuticals Inc.
$5.84-7.30%20
GRIGri Bio Inc.
$1.12+0.00%20
PSTVPlus Therapeutics Inc
No recent price20
EVFMEvofem Biosciences Inc.
$1.00+0.00%15

Spot a number that looks wrong? Check it in PPCB's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PPCB

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.